Pennsylvania's Thomas Jefferson University and its Sidney Kimmel Medical College are facing allegations that several scholarship programs discriminate based on race, according to a newly filed federal civil rights complaint.

On Thursday, the Equal Protection Project filed a complaint with the U.S. Department of Health and Human Services Office for Civil Rights, alleging that Thomas Jefferson University (TJU) and its Sidney Kimmel Medical College (SKMC) operate or promote five scholarship programs that unlawfully discriminate based on race, color and/or national origin in violation of Title VI of the Civil Rights Act and Section 1557 of the Affordable Care Act.

The U.S. military carried out a lethal strike Thursday on a vessel it said was involved in drug trafficking in the Eastern Pacific, killing three men the command described as "narco-terrorists," according to U.S. Southern Command (SOUTHCOM).

"On June 18, at the direction of #SOUTHCOM commander Gen. Francis L. Donovan, Joint Task Force Southern Spear conducted a lethal kinetic strike on a vessel operated by Designated Terrorist Organizations," SOUTHCOM said in a statement.

Most skincare addresses what happens after your skin ages: the appearance of wrinkles, loss of visible firmness, and dullness. But four PhD longevity scientists asked a different question: what if you could target the cellular process that causes visible aging in the first place?

Their answer is OS-01, the first peptide scientifically proven to address senescent cells — the damaged "zombie cells" that accumulate with age and accelerate visible skin decline. The result: the first topical clinically validated to address visible skin aging at the source. In a double-blind 12-week clinical study of OS-01 FACE:

This isn't skincare with better marketing. It's skincare with better science. And real results.

Get 15% off + free gifts

^{*Explore the claims at oneskin.co}